Drysdale

United Kingdom
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Paediatric
  • Immunocompromised host
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

DELong#3

Italy
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Probiotic

Dalton

United Kingdom
|
2023-2023
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Probiotic

COVA / RestPlus

The Netherlands
|
2022-2023
  • Adults
  • Elderly
  • Paediatric
  • People at high risk of STIs
  • Men who have sex with men
  • Healthcare workers
  • Hospital wide
  • Infectious diseases unit
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Agunbiade

United Kingdom
|
2022-2022
  • Adults
  • General population
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

ALL-VASCOR

Poland
|
2023
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Allopurinol

Amsterdam Cohort Studies

The Netherlands
|
2022-2022
  • Adults
  • People at high risk of STIs
  • Men who have sex with men
  • Primary care
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination

Antinori

Italy
|
2022-2022
  • Adults
  • Fragile population
  • People living with HIV
  • PrEP users
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Zuiani

United Kingdom United States of America
|
2023-2026
  • Adults
  • General population
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • BNT166a

BLOC

Austria Finland Germany Spain Switzerland
|
2023-2024
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • BC 007